Mice deficient in nuclear factor (NF)-κB/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture G Franzoso, L Carlson, L Poljak, EW Shores, S Epstein, A Leonardi, ... The Journal of experimental medicine 187 (2), 147-159, 1998 | 577 | 1998 |
Protection against lethal influenza virus challenge by RNA interference in vivo SM Tompkins, CY Lo, TM Tumpey, SL Epstein Proceedings of the National Academy of Sciences 101 (23), 8682-8686, 2004 | 561 | 2004 |
Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1 SM Tompkins, ZS Zhao, CY Lo, JA Misplon, T Liu, Z Ye, RJ Hogan, Z Wu, ... Emerging infectious diseases 13 (3), 426, 2007 | 394 | 2007 |
Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein SL Epstein, W Kong, JA Misplon, CY Lo, TM Tumpey, L Xu, GJ Nabel Vaccine 23 (46-47), 5404-5410, 2005 | 389 | 2005 |
Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature SL Epstein The Journal of infectious diseases 193 (1), 49-53, 2006 | 345 | 2006 |
TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection I Jelinek, JN Leonard, GE Price, KN Brown, A Meyer-Manlapat, ... The Journal of Immunology 186 (4), 2422-2429, 2011 | 237 | 2011 |
Mechanism of protective immunity against influenza virus infection in mice without antibodies SL Epstein, CY Lo, JA Misplon, JR Bennink The Journal of Immunology 160 (1), 322-327, 1998 | 233 | 1998 |
DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice SL Epstein, TM Tumpey, JA Misplon, CY Lo, LA Cooper, K Subbarao, ... Emerging infectious diseases 8 (8), 796, 2002 | 229 | 2002 |
Critical roles for the Bcl-3 oncoprotein in T cell–mediated immunity, splenic microarchitecture, and germinal center reactions G Franzoso, L Carlson, T Scharton-Kersten, EW Shores, S Epstein, ... Immunity 6 (4), 479-490, 1997 | 216 | 1997 |
Interferon (IFN) consensus sequence-binding protein, a transcription factor of the IFN regulatory factor family, regulates immune responses in vivo through control of … NA Giese, L Gabriele, TM Doherty, DM Klinman, L Tadesse-Heath, ... The Journal of experimental medicine 186 (9), 1535-1546, 1997 | 193 | 1997 |
Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or γδ T cells KA Benton, JA Misplon, CY Lo, RR Brutkiewicz, SA Prasad, SL Epstein The Journal of Immunology 166 (12), 7437-7445, 2001 | 169 | 2001 |
Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, beta2-microglobulin-deficient, and J chain-deficient mice. SL Epstein, CY Lo, JA Misplon, CM Lawson, BA Hendrickson, EE Max, ... Journal of immunology (Baltimore, Md.: 1950) 158 (3), 1222-1230, 1997 | 168 | 1997 |
Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses GE Price, MR Soboleski, CY Lo, JA Misplon, C Pappas, KV Houser, ... Vaccine 27 (47), 6512-6521, 2009 | 158 | 2009 |
Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses GE Price, MR Soboleski, CY Lo, JA Misplon, MR Quirion, KV Houser, ... PloS one 5 (10), e13162, 2010 | 152 | 2010 |
Cross-protective immunity to influenza A viruses SL Epstein, GE Price Expert review of vaccines 9 (11), 1325-1341, 2010 | 123 | 2010 |
Antigen-antibody interaction and monoclonal antibodies IA Berzofsky Fundamental immunology, 421-425, 1993 | 122 | 1993 |
Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase. SL Epstein, JA Misplon, CM Lawson, EK Subbarao, M Connors, ... Journal of immunology (Baltimore, Md.: 1950) 150 (12), 5484-5493, 1993 | 113 | 1993 |
Comparison of vaccines for induction of heterosubtypic immunity to influenza A virus: cold-adapted vaccine versus DNA prime-adenovirus boost strategies CY Lo, Z Wu, JA Misplon, GE Price, C Pappas, WP Kong, TM Tumpey, ... Vaccine 26 (17), 2062-2072, 2008 | 99 | 2008 |
Impact of cross-protective vaccines on epidemiological and evolutionary dynamics of influenza N Arinaminpathy, O Ratmann, K Koelle, SL Epstein, GE Price, C Viboud, ... Proceedings of the National Academy of Sciences 109 (8), 3173-3177, 2012 | 82 | 2012 |
Induction of anti-H–2 antibodies without alloantigen exposure by in vivo administration of anti-idiotype JA Bluestone, SO Sharrow, SL Epstein, K Ozato, DH Sachs Nature 291 (5812), 233-235, 1981 | 79 | 1981 |